ConductScience.org, home

Comparison · NCT03229538-8b80392f

Methylprednisolone Arm vs Placebo Arm: Number of Participants With Occurrence of Any One or More of the Following STS-CHSD-defined Major Post-operative Infectious Complications: Postprocedural Infective Endocarditis, Pneumonia, Sepsis, Deep Wound Infection, Mediastinitis.

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Methylprednisolone Arm vs Placebo Arm: Number of Participants With Occurrence of Any One or More of the Following STS-CHSD-defined Major Post-operative Infectious Complications: Postprocedural Infective Endocarditis, Pneumonia, Sepsis, Deep Wound Infection, Mediastinitis. Trial comparisons, record NCT03229538-8b80392f. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03229538-8b80392f

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.05180.03670.0725wilson
Risk in group 20.03990.0270.0587wilson
Risk difference, group 1 minus group 20.0118-0.01230.0363newcombe hybrid score
Risk ratio, group 1 over group 21.30.772.18log
Odds ratio, group 1 over group 21.310.7612.26log
Number needed to treat, for one more participant with the outcome on Methylprednisolone Arm than on Placebo Arm84.6from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Methylprednisolone ArmIV Methylprednisolone~Methylprednisolone: IV Steroid pre-operative and intra-operative31599OG000
Group 2Placebo ArmIV Isotonic Saline~Isotonic saline: Isotonic saline pre-operative and intra-operative24601OG001

Outcome

Type
SECONDARY
Title
Number of Participants With Occurrence of Any One or More of the Following STS-CHSD-defined Major Post-operative Infectious Complications: Postprocedural Infective Endocarditis, Pneumonia, Sepsis, Deep Wound Infection, Mediastinitis.
Description
Time frame
Until hospital discharge, up to 4 months
Population

Source ClinicalTrials.gov

Trial

Title
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
NCT number
NCT03229538
Phases
PHASE3
Conditions
Congenital Heart Disease in Children, Inflammatory Response
Interventions
Methylprednisolone, Isotonic saline
Lead sponsor
Kevin Hill
Results first posted
2023-05-10

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03229538-8b80392f